Foundation Medicine, Inc.

Release Summary

Foundation Medicine Receives FDA Approval of FoundationFocus CDxBRCA as a Companion Diagnostic for Rubraca (rucaparib) for the Treatment of Women with Ovarian Cancer

Foundation Medicine, Inc.